Floatz logo

Therapeutic Asset Ratings

534 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Bg-C0902
Cancer
BeOne MedicinesP1C (36)
Bg-C0979
Cancer
BeOne MedicinesP1C (36)
Bg-C137
Cancer
BeOne MedicinesP1C (36)
Bg-C9074
Cancer
BeOne MedicinesP1C (36)
bl0006
Cancer
Shanghai Best-Link Bioscience, LLCP1C (36)
bl0020
Cancer
Shanghai Best-Link Bioscience, LLCP1C (36)
BMS-986500
Cancer
Bristol-Myers SquibbP1C (36)
BNT317
Cancer
BioNTech SEP1C (36)
Bpi-21668
Cancer
Betta Pharmaceuticals Co., Ltd.P1C (36)
Bpi-371153
Cancer
Betta Pharmaceuticals Co., Ltd.P1C (36)
Bpi-460372
Cancer
Betta Pharmaceuticals Co., Ltd.P1C (36)
bry805
Cancer
BioRay Pharmaceutical Co., Ltd.P1C (36)
Bsi-082
Cancer
Lei ZhengP1C (36)
bt02
Cancer
Biotroy TherapeuticsP1C (36)
bt02 monoclonal antibody
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1C (36)
Btx-1188
Cancer
Biotheryx, Inc.P1C (36)
Btx-A51
Cancer
Edgewood Oncology Inc.P1C (36)
Canagliflozin
Advanced Solid Tumor
Faeth TherapeuticsP1C (36)
Cbp-1008
Cancer
Coherent Biopharma (Suzhou) Co., Ltd.P1C (36)
cf33-hnis
Cancer
Imugene LimitedP1C (36)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Cancer
EMD Serono Research & Development Institute, Inc.P1C (36)
Chs-006
Cancer
Coherus Oncology, Inc.P1C (36)
cht101
Cancer
Zhejiang UniversityP1C (36)
Cid-078 Monotherapy
Cancer
Circle PharmaP1C (36)
Cln-617
Cancer
Cullinan Therapeutics Inc.P1C (36)
Showing 301 to 325 of 534 assets
PreviousPage 13 of 22Next